Bristol-Myers Squibb (NYSE:BMY) and Evotec have advanced molecular glue candidate BMS-986506 into Phase 1 trials for clear ...

Bristol Myers Squibb’s mezigdomide has scored its first phase 3 win, with the Cereblon E3 ligase modulator (CELMoD) tied to a statistically significant improvement in progression-free survival (PFS) ...

BMS Syllabus 2026: The Bachelor of Management Studies (BMS) program for the 2026 academic year has changed to a comprehensive, multidisciplinary framework in accordance with the National Education ...

Icotyde, co-developed by Johnson & Johnson and Protagonist Therapeutics, is backed by data from the Phase 3 ICONIC program, which, among other advantages, showed significant superiority over Bristol ...

A death cross forms when a stock’s 50-day moving average crosses below its 200-day moving average, signaling a potential downtrend. Right now, Bristol Myers Squibb (NYSE: BMY), FedEx (NYSE: FDX), and ...

Controversial policies about parental rights, school budget questions and academic standards were topics of strong ...

Schneider Electric and JLL examine nine measures that could help healthcare organizations save money and reduce carbon dioxide emissions as they upgrade their infrastructure.

Study marks the first positive Phase 3 study for mezigdomide and the second positive Phase 3 study for the Bristol Myers Squibb CELMoD programPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #CELMoD--Bristol ...

The third mural in the Batesville Community Education Foundation’s (BCEF) 2025-26 Art on Main student art program in downtown ...

Burton Middle School put on a Showcase Extravaganza for future sixth grade students as well as their parents on Thursday.

As the event’s partner country, Brazil reinforces its position as Latin America’s largest economy, backed by robust and ...